American International Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,160
| Closed | -$76.2K | – | 2999 |
|
|
2024
Q1 | $76.2K | Sell |
5,160
-44
| -0.8% | -$650 | ﹤0.01% | 2655 |
|
|
2023
Q4 | $69.8K | Sell |
5,204
-21
| -0.4% | -$282 | ﹤0.01% | 2727 |
|
|
2023
Q3 | $64.4K | Buy |
5,225
+186
| +4% | +$2.29K | ﹤0.01% | 2748 |
|
|
2023
Q2 | $62K | Buy |
+5,039
| New | +$62K | ﹤0.01% | 2824 |
|
|
2018
Q2 | – | Sell |
-10,425
| Closed | -$66K | – | 3204 |
|
|
2018
Q1 | $66K | Sell |
10,425
-562
| -5% | -$3.56K | ﹤0.01% | 2828 |
|
|
2017
Q4 | $89K | Buy |
10,987
+55
| +0.5% | +$446 | ﹤0.01% | 2782 |
|
|
2017
Q3 | $125K | Buy |
10,932
+815
| +8% | +$9.32K | ﹤0.01% | 2536 |
|
|
2017
Q2 | $99K | Buy |
10,117
+564
| +6% | +$5.52K | ﹤0.01% | 2731 |
|
|
2017
Q1 | $231K | Buy |
9,553
+633
| +7% | +$15.3K | ﹤0.01% | 2093 |
|
|
2016
Q4 | $286K | Sell |
8,920
-23
| -0.3% | -$737 | ﹤0.01% | 1962 |
|
|
2016
Q3 | $447K | Buy |
8,943
+13
| +0.1% | +$650 | ﹤0.01% | 1680 |
|
|
2016
Q2 | $379K | Buy |
8,930
+740
| +9% | +$31.4K | ﹤0.01% | 1749 |
|
|
2016
Q1 | $539K | Hold |
8,190
| – | – | ﹤0.01% | 1960 |
|
|
2015
Q4 | $509K | Sell |
8,190
-15
| -0.2% | -$932 | ﹤0.01% | 2021 |
|
|
2015
Q3 | $549K | Buy |
8,205
+10
| +0.1% | +$669 | ﹤0.01% | 1941 |
|
|
2015
Q2 | $797K | Buy |
8,195
+349
| +4% | +$34K | ﹤0.01% | 1771 |
|
|
2015
Q1 | $733K | Hold |
7,846
| – | – | ﹤0.01% | 1858 |
|
|
2014
Q4 | $698K | Sell |
7,846
-463
| -6% | -$41.2K | ﹤0.01% | 1855 |
|
|
2014
Q3 | $574K | Buy |
8,309
+146
| +2% | +$10.1K | ﹤0.01% | 2010 |
|
|
2014
Q2 | $468K | Sell |
8,163
-315
| -4% | -$18.1K | ﹤0.01% | 2231 |
|
|
2014
Q1 | $336K | Buy |
8,478
+200
| +2% | +$7.93K | ﹤0.01% | 2386 |
|
|
2013
Q4 | $348K | Buy |
8,278
+409
| +5% | +$17.2K | ﹤0.01% | 2299 |
|
|
2013
Q3 | $235K | Buy |
7,869
+6,538
| +491% | +$195K | ﹤0.01% | 2580 |
|
|
2013
Q2 | $70.5K | Buy |
+1,331
| New | +$70.5K | ﹤0.01% | 3384 |
|